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Methods: A retrospective cohort study was conducted at
the University of Tokyo Hospital, comprising 1,150 beds, with
specialty services including intensive care and transplanta-
tion in Japan, from January 2003 to September 2009.
Results: During this study period, 7,216 positive blood
cultures were identiﬁed. Of these, 87 (1.2%) blood cul-
tures from 54 patients showed S. maltophilia growth. The
mean age of the patients was 53.3± 3.0 years. In 52
patients (96%), S. maltophilia bacteremia was hospitalac-
quired, in particular, in 49 patients (91%) it developed after
prolonged hospitalization of >2 weeks. Forty-one patients
(76%) had an indwelling central venous catheter (CVC),
50 (93%) had received antibiotic therapy, 48 (89%) had
underlying malignancy, 11 (20%) had diabetes mellitus, and
11 (20%) were receiving corticosteroid therapy. In 19% of
all the cases of bacteremia, polymicrobial isolates were
conﬁrmed. The overall and bacteremia-related mortality
rates were 39% and 26%, respectively. The most common
sources of bacteremia were CVC (33%) and pneumonia (15%);
the source was unknown in 20% cases. Tests for antibi-
otic susceptibility revealed that the isolates were most
sensitive to trimethoprimsulfamethoxazole (79%). Only 47%
and 43% of the isolates were susceptible for ceftazidime
and ciproﬂoxacin, respectively. Univariate analysis revealed
that bacteremia originating from the pneumonia, patients
treated with inappropriate antibiotics, and patients with a
persistent indwelling CVC had a signiﬁcant higher mortality
rate (P < 0.0001, P < 0.0001, P = 0.0027, respectively).
Conclusion: S. maltophilia is an important pathogen, par-
ticularly, in immunocompromised hosts. Isolation of this
organism from a blood culture should prompt a careful
review of the patient, with particular emphasis on removal
of an indwelling CVC and commencement of appropriate
antibiotic therapy. In this study, we noticed an increas-
ing trend of resistance to ceftazidime, cefepime, and
ciproﬂoxacin. Therefore, we believe that proper usage of
antibiotics is important for infection control.
doi:10.1016/j.ijid.2010.02.2054
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Prevalence of mecA, aap genes and slime layer formation
and its association with antibiotic resistance in isolated
Staphylococcus epidermidis of TUMS hospitals health care
staffs
M.R. Pourmand ∗, Z. Abdossamadi, M.H. Salari
Tehran University of Medical Sciences, Tehran, Iran, (Islamic
Republic of)
Background: Staphylococcus epidermidis strains are fre-
quently associated with catheterrelated infection, acute
bacteremia and hospital-acquired infection. Some of the
isolates have extracellular matrix called slime. The recent
studies show that slime-forming bacteria are more resistant
to antibiotics than planktonic bacteria. In S.epidermidis, the
accumulation associated protein (aap) is essential to bioﬁlm
development and is involved in the accumulation phase of
bioﬁlm formation. methicillin resistance is mediated by the
mecA gene. However in contrast to MRSA,very little atten-
tion is paid to MRSE. The aim of this study was to determine
the prevalence of mecA, aap gene and slime production in
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.epidermidis isolates and antibiotic resistance in nasophar-
nx isolates of health care personnel.
Methods: A descriptive cross sectional study was per-
ormed on 163 isolates. These were collected from July to
ecember 2008. S. epidermidis isolates tested for slime pro-
uction onto CRA and antibiotic resistance. The extracted
NA of S. epidermidis isolates were examined by PCR involv-
ng speciﬁc primers for mecA and aap genes.
Results: Among 163 collected nasal swabs 99 (60.7) were
. epidermidis. Of these 35.3 isolates produced slime. Sig-
iﬁcant relation between slime production and resistance
o Penicillin, oxacillin (p < 0.0001), tetracycline (P = 0.0005),
rythromycin (P = 0.001) and clindamycin (0.003) was found.
5.8% and 94.8% isolates were PCR-positive for mecA and
ap, respectively.
Conclusion: Surveillance of nasal colonization with slime-
orming MRSE in health care workers might provide useful
nformation for the establishment of infection control pro-
edures toward these bacteria.
oi:10.1016/j.ijid.2010.02.2055
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Background: To determine rate, microorganism proﬁle,
acterial resistance, extra length of stay (LOS) and extra
ortality of Central Line associated Bloodstream Infection
CLAB) in intensive care units (ICUs) of 23 countries in
NICC hospitals in Argentina, Brazil, China, Colombia, Costa
ica, Cuba, Ecuador, El Salvador, India, Jordan, Kosovo,
ebanon, Macedonia, Mexico, Morocco„ Pakistan, Panama,
eru, Philippines, Serbia, Thailand, Tunisia, and Turkey.
Methods: An open label, prospective cohort, active
evice-associated infection (DAI) surveillance study was
onducted on adult, pediatric and neonatal patients admit-
ed to tertiary-care ICUs. DAI rates were collected from
66 ICUs, and were recorded by using CDC-NNIS deﬁni-
ions. Microorganism proﬁle, bacterial resistance, LOS and
ortality data were collected in 128 out of the 166 ICUs.
ata were collected from patients with and without DAI
sing the INICC protocol, forms and methods, which pro-
ided researchers with a general view of patients’ outcomes,
llowing researchers to suspect DAI and avoid possible DAI
missions if no cultures were done. Patients with and with-
ut DAI can be matched to calculate LOS, costs, and extra
ortality. Data were uploaded and analyzed at INICC ofﬁce.
tatistical analysis was performed using Chi-square test.
< 0.05 was considered signiﬁcant.
Results: We collected data from 01/02 to 11/08, repre-
enting 563,322 CL days. The pooled CLAB rate was 8.06 per
000 CL days; data stratiﬁed by ICU type are shown in Table.
verall 17.1% of all CLAB were caused by Staphylococcus
ureus (83.1% were MRSA); 17.1% by Coagulase-negative-
taphylococci (80.1% were methicilin resistant); 13.9%
y Acinetobacter sp (83.3% were Piperaciline-Tazobactam
esistant); and 11.8% by Pseudomonas sp (42.2% were
mipenem resistant). The LOS of patients without DAI was
.3 days; and of patients with CLAB, 16.7 days (RR, 3.14),
epresenting 11.4 extra days. 7,464 out of 52,549 (14.2%)
atients without any DAI died; 397 out of 1,305 patients
30.4%) with CLAB died, the extra mortality being 16.2% (RR,
.14, 95% CI, 1.94—2.37, P, 0.0001).
Conclusion: Pooled CLAB rate of 8.02 per 1000 CL days
as higher than the 2.0 rate (medical surgical ICUs) per
000 CL days published by CDC-NNIS. Patients with CLAB had
signiﬁcantly higher LOS, with 11.4 extra days, and extra
ortality of 16.2%.
oi:10.1016/j.ijid.2010.02.2056
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Background: To determine rate and consequences of
entral line associated bloodstream infection (CLAB) in 1
erman surgical intensive care unit (ICU) cooperating with
he International Nosocomial Infection Control Consortium
INICC).
Methods: We performed an open label, prospective
ohort, active surveillance study in adult ICU patients of a
erman tertiary-care hospital. At the ICU, for all patients
emi-rigid and/or glass infusion containers and stopcocks
ere used. INICC (www.inicc.org) protocols, forms and
ethods were used. According to these methods, data is
ollected from patients with and without healthcare associ-
ted infections (HAIs) enabling the match for variables such
s age, gender, underlying diseases, diagnosis, severity-of-
llness, invasive device use in order to calculate risk factors
nd outcome parameters. In this study, length of stay (LOS)
nd extra mortality are presented. Statistical analysis was
erformed using Chi-square test. P < 0.05 was considered
igniﬁcant.
Results: 447 patients were enrolled from 02/08 to 10/08,
epresenting 2,844 bed days. The overall CLAB rate was 7.86
er 1000 central line (CL) days. Overall, 33.3% of CLABs were
aused by Staphylococcus aureus (n = 4), 0% were methicillin
esistant; 33.3% by coagulasenegative staphylococci (n = 4),
00% were methicillin resistant; and 33.3% by Enterococcus
pp. (n = 4), 0% were vancomycin resistant. LOS of patients
ithout HAI was 4.5 days; LOS of patients with CLAB was 18.9
ays (RR, 4.19; 95% CI, 3.68 - 4.77; P < 0.001), representing
4.4 extra days. 20 of 406 (5%) patients without HAI died,
hereas the course of 2 of 14 patients (14%) with CLAB was
atal. Extra mortality was 9% (RR, 2.90; 95% CI, 0.68 - 12.41,
= 0.13).
Conclusion: In this study, the CLAB rate of 7.86 per 1000
L days is lower than the published rate of 9.2 per 1000 CL
ays observed in other hospitals cooperating in INICC. INICC
ethods allow for the comparison between patients with
nd without HAIs; LOS in patients with CLAB was signiﬁcantly
